- #1085680
- Sanofi Pasteur #49281041810
Fluzone® Quadrivalent 2018 - 2019 Flu Vaccine 60 mcg / 0.5 mL Indicated for People 6 Months of Age and Older Single-Dose Vial 0.5 mL
FLUZONE 2018 QUAD, SDV 0.5ML 10DOSE/BX)
No Image
Features
- Fluzone Quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
- Fluzone Quadrivalent is indicated for active immunization in persons 6 Months of age and older
- Single-dose vial, 0.5 mL, for persons 36 months of age and older
- More …
Product Details Email
Product Specifications
McKesson # | 1085680 |
Manufacturer # | 49281041810 |
Brand | Fluzone® Quadrivalent 2018 - 2019 |
Manufacturer | Sanofi Pasteur |
Country of Origin | Unknown |
Application | Flu Vaccine |
Container Type | Single-Dose Vial |
Dosage Form | Injection |
Generic Drug Name | Influenza Virus Vaccine, Quadrivalent Inactivated, Preservative Free |
NDC Number | 49281-0418-10 |
Storage Requirements | Requires Refrigeration |
Strength | 60 mcg / 0.5 mL |
Type | Intramuscular |
UNSPSC Code | 51201608 |
User | Indicated for People 6 Months of Age and Older |
Volume | 0.5 mL |
Features
- Fluzone Quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine
- Fluzone Quadrivalent is indicated for active immunization in persons 6 Months of age and older
- Single-dose vial, 0.5 mL, for persons 36 months of age and older
- Fluzone Quadrivalent (Influenza Vaccine) for intramuscular injection is an inactivated influenza vaccine, prepared from influenza viruses propagated in embryonated chicken eggs
- Fluzone Quadrivalent is standardized according to United States Public Health Service requirements and is formulated to contain HA of each of the following four influenza strains recommended for the 2017-2018 influenza season: A/Michigan/45/2015 X-275 (H1N1), A/Hong Kong/4801/2014 X-263B (H3N2), B/Phuket/3073/2013 (B Yamagata lineage), and B/Brisbane/60/2008 (B Victoria lineage)
- The single-dose, pre-filled syringe (0.25 mL and 0.5 mL) and the single-dose vial (0.5 mL) are manufactured and formulated without thimerosal or any other preservative
More Information
Professionals Also Viewed
No Image
- #1220908
- 86
- Glaxo Smith Kline #58160090952
- Fluarix is an inactivated influenza vaccine indicated for active immun …
- Fluarix is approved for use in persons 6 months of age and older
- FLUARIX QUADRIVALENT does not contain thimerosal
No Image
- # 1220909
- 52
- Glaxo Smith Kline #19515081452
- FLULAVAL QUADRIVALENT is a vaccine indicated for active immunization f …
- FLULAVAL QUADRIVALENT is approved for use in persons 6 months of age a …
- FLULAVAL QUADRIVALENT is formulated without preservatives and does not …